Rallis India Ltd
Rallis India, a Tata Group company Group Co., has a history of over 150 years. The company is into manufacturing of Agrochemicals and is present across the value chain of agriculture inputs - from seeds to organic plant growth nutrients. Rallis is also in the business of contract manufacturing for global corporations. [1]
- Market Cap ₹ 3,755 Cr.
- Current Price ₹ 193
- High / Low ₹ 289 / 182
- Stock P/E 25.6
- Book Value ₹ 91.2
- Dividend Yield 1.56 %
- ROCE 13.6 %
- ROE 10.2 %
- Face Value ₹ 1.00
Pros
- Company has been maintaining a healthy dividend payout of 29.1%
Cons
- Company has a low return on equity of 12.6% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1,053 | 1,168 | 1,315 | 1,519 | 1,493 | 1,288 | 1,386 | 1,498 | 1,984 | 2,252 | 2,429 | 2,604 | 2,952 | |
860 | 968 | 1,110 | 1,269 | 1,237 | 1,079 | 1,148 | 1,270 | 1,741 | 1,987 | 2,104 | 2,323 | 2,671 | |
Operating Profit | 193 | 200 | 205 | 250 | 255 | 209 | 238 | 228 | 243 | 265 | 325 | 281 | 281 |
OPM % | 18% | 17% | 16% | 16% | 17% | 16% | 17% | 15% | 12% | 12% | 13% | 11% | 10% |
14 | -10 | 11 | 6 | 2 | 5 | 168 | 9 | 30 | 46 | 49 | 22 | 16 | |
Interest | 6 | 13 | 15 | 10 | 7 | 10 | 4 | 6 | 8 | 10 | 7 | 7 | 9 |
Depreciation | 17 | 27 | 29 | 36 | 45 | 38 | 42 | 41 | 46 | 62 | 64 | 74 | 88 |
Profit before tax | 184 | 150 | 173 | 209 | 206 | 165 | 359 | 191 | 219 | 239 | 304 | 222 | 200 |
Tax % | 31% | 32% | 31% | 30% | 29% | 24% | 26% | 26% | 29% | 22% | 25% | 26% | |
Net Profit | 126 | 101 | 119 | 146 | 145 | 126 | 266 | 141 | 154 | 185 | 229 | 164 | 147 |
EPS in Rs | 6.49 | 5.21 | 6.14 | 7.53 | 7.48 | 6.49 | 13.68 | 7.28 | 7.93 | 9.54 | 11.76 | 8.45 | 7.55 |
Dividend Payout % | 31% | 42% | 37% | 32% | 33% | 39% | 27% | 34% | 32% | 26% | 26% | 36% |
Compounded Sales Growth | |
---|---|
10 Years: | 8% |
5 Years: | 13% |
3 Years: | 9% |
TTM: | 15% |
Compounded Profit Growth | |
---|---|
10 Years: | 4% |
5 Years: | 2% |
3 Years: | 3% |
TTM: | -21% |
Stock Price CAGR | |
---|---|
10 Years: | 5% |
5 Years: | -4% |
3 Years: | 4% |
1 Year: | -17% |
Return on Equity | |
---|---|
10 Years: | 14% |
5 Years: | 13% |
3 Years: | 13% |
Last Year: | 10% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Sep 2022 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | |
Reserves | 484 | 534 | 602 | 694 | 779 | 899 | 1,106 | 1,159 | 1,266 | 1,391 | 1,572 | 1,677 | 1,754 |
92 | 116 | 84 | 40 | 75 | 36 | 22 | 21 | 73 | 94 | 76 | 93 | 175 | |
365 | 360 | 361 | 384 | 359 | 356 | 404 | 533 | 801 | 944 | 920 | 1,069 | 1,193 | |
Total Liabilities | 961 | 1,029 | 1,066 | 1,137 | 1,232 | 1,310 | 1,551 | 1,733 | 2,159 | 2,447 | 2,587 | 2,858 | 3,142 |
216 | 352 | 372 | 395 | 373 | 342 | 350 | 351 | 581 | 593 | 631 | 771 | 845 | |
CWIP | 152 | 50 | 27 | 13 | 14 | 24 | 23 | 25 | 51 | 76 | 164 | 130 | 127 |
Investments | 152 | 181 | 193 | 219 | 232 | 305 | 534 | 390 | 109 | 302 | 283 | 212 | 49 |
441 | 446 | 474 | 510 | 614 | 639 | 644 | 968 | 1,419 | 1,476 | 1,508 | 1,745 | 2,121 | |
Total Assets | 961 | 1,029 | 1,066 | 1,137 | 1,232 | 1,310 | 1,551 | 1,733 | 2,159 | 2,447 | 2,587 | 2,858 | 3,142 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
88 | 99 | 147 | 155 | 64 | 218 | 353 | -5 | 79 | 338 | 216 | 166 | |
-134 | -66 | -39 | -65 | -42 | -134 | -275 | 95 | -51 | -246 | -162 | -103 | |
46 | -34 | -94 | -105 | -24 | -52 | -74 | -92 | -52 | -74 | -67 | -61 | |
Net Cash Flow | -1 | -1 | 14 | -15 | -2 | 32 | 3 | -1 | -23 | 18 | -13 | 1 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 32 | 26 | 40 | 33 | 50 | 52 | 59 | 89 | 82 | 73 | 61 | 63 |
Inventory Days | 129 | 123 | 88 | 99 | 114 | 128 | 121 | 170 | 224 | 193 | 200 | 227 |
Days Payable | 160 | 120 | 99 | 101 | 85 | 95 | 113 | 167 | 178 | 176 | 156 | 182 |
Cash Conversion Cycle | 0 | 28 | 29 | 32 | 80 | 85 | 68 | 92 | 129 | 90 | 105 | 107 |
Working Capital Days | -6 | 9 | -3 | 16 | 46 | 51 | 51 | 93 | 92 | 60 | 67 | 71 |
ROCE % | 37% | 28% | 26% | 30% | 26% | 19% | 20% | 17% | 18% | 17% | 19% | 14% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
8 Mar - Has reference to Regulation 30(6) of the SEBI (LODR) Regulations, 2015. In accordance with the said Regulation(s), please find enclosed the details of scheduled meeting …
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
24 Feb - Has reference to Regulation 30(6) of the SEBI (LODR) Regulations, 2015. In accordance with the said Regulation(s), please find enclosed the details of scheduled meeting …
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
3 Feb - Has reference to Regulation 30(6) of the SEBI (LODR) Regulations, 2015. In accordance with the said Regulation(s), please find enclosed the details of scheduled meeting …
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
31 Jan - Has reference to Regulation 30(6) of the SEBI (LODR) Regulations, 2015. In accordance with the said Regulation(s), please find enclosed the details of meetings with …
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 30 Jan
Annual reports
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2011
from nse
-
Financial Year 2010
from bse
-
Financial Year 2010
from nse
Concalls
-
Jan 2023Transcript PPT
-
Oct 2022Transcript PPT
-
Jul 2022Transcript PPT
-
Apr 2022TranscriptPPT
-
Apr 2022Transcript PPT
-
Jan 2022Transcript PPT
-
Oct 2021Transcript PPT
-
Jul 2021TranscriptNotesPPT
-
Apr 2021TranscriptNotesPPT
-
Jan 2021TranscriptNotesPPT
-
Oct 2020TranscriptNotesPPT
-
Jul 2020Transcript PPT
-
May 2020TranscriptNotesPPT
-
Jan 2020Transcript PPT
-
Oct 2019TranscriptNotesPPT
-
Jul 2019TranscriptNotesPPT
-
Jan 2019TranscriptNotesPPT
-
Oct 2018TranscriptNotesPPT
-
May 2018TranscriptNotesPPT
-
Apr 2016TranscriptNotesPPT
Market share
Crop protection and plant growth nutrients have a market share of 6% in the domestic market and Seeds have a market share of 3% in the domestic market.[1]
In FY22, co. had 12% share in the global metribuzin market which is expected to increase with recent capacity expansions.[2]